Centene Corporation Announces Pricing Of Notes

                Centene Corporation Announces Pricing Of Notes

PR Newswire

ST. LOUIS, Nov. 2, 2012

ST. LOUIS, Nov. 2, 2012 /PRNewswire/ -- Centene Corporation (NYSE: CNC)
("Centene") today announced that on November 2, 2012 it priced $175 million
aggregate principal amount of its 5.75% Senior Notes due 2017 (the "Senior
Notes"), an increase from the $150 million initially announced, in a public
offering made pursuant to a registration statement and a related preliminary
prospectus supplement filed by Centene with the Securities and Exchange
Commission ("SEC"). The underwriters were led by Barclays and Wells Fargo
Securities, with Allen & Company LLC, Fifth Third Securities, Inc., SunTrust
Robinson Humphrey and US Bancorp as co-managers of the offering. The Senior
Notes will be issued at 106.00% plus accrued interest from June 1, 2012 and
bear interest at 5.75%, resulting in a yield of 4.288%. The Senior Notes are
an additional issuance of, will be fully fungible with, rank equally with, and
form a single series with Centene's $250 million 5.75% Senior Notes due 2017
issued on May 27, 2011, and will have the same CUSIP number. The offering is
expected to close on or about November 7, 2012. The issuance of the Senior
Notes will be subject to customary closing conditions.

Centene intends to use the net proceeds of the offering for general corporate
purposes, primarily including the funding of statutory capital.

This press release shall not constitute an offer to sell or the solicitation
of an offer to buy, nor shall there be any sale of these securities in any
jurisdiction in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any such
jurisdiction. The offering is being made by means of a prospectus and the
related preliminary prospectus supplement. Before you invest, you should read
the prospectus and the related preliminary prospectus supplement, the
registration statement and other documents that Centene has filed with the SEC
for more complete information about Centene and this offering. Copies of the
prospectus, the related preliminary prospectus supplement and registration
statement can be obtained at no charge from Barclays Capital Inc., c/o
Broadridge Financial Solutions, 1155 Long Island Avenue, New York, NY 11717 or
by telephone at 888-603-5847 or e-mail at barclaysprospectus@broadridge.com.
Investors may also obtain these and other documents Centene has filed with the
Securities and Exchange Commission for free by visiting the EDGAR system on
the SEC's website at www.sec.gov.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare
enterprise that provides programs and related services to the rising number of
under-insured and uninsured individuals. Many receive benefits provided under
Medicaid, including the State Children's Health Insurance Program (CHIP), as
well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in
addition to other state-sponsored programs, and Medicare (Special Needs
Plans). Centene's CeltiCare subsidiary offers states unique, "exchange based"
and other cost-effective coverage solutions for low-income populations. The
Company operates local health plans and offers a range of health insurance
solutions. It also contracts with other healthcare and commercial
organizations to provide specialty services including behavioral health, life
and health management, managed vision, telehealth services, and pharmacy
benefits management. More information regarding Centene is available at
www.centene.com.

The information provided in this press release contains forward-looking
statements that relate to the public offering of senior notes, including
without limitation, statements regarding the completion of the offering and
the use of proceeds. Actual events or results may differ materially from those
contained in the forward-looking statements.  The Company's reports to the SEC
contain additional information relating to additional factors that could cause
actual results to differ from these forward-looking statements. The Company
disclaims any obligation to update this forward-looking financial information
in the future.

SOURCE Centene Corporation

Website: http://www.centene.com
Contact: Investor Relations Inquiries, Edmund E. Kroll, Senior Vice President,
Finance and Investor Relations, (212) 759-0382; or Media Inquiries, Deanne
Lane, Vice President, Media Affairs, (314) 725-4477